Assefa S

No ORCID on file · 1 paper in corpus

2021

Extending Adjuvant Endocrine Therapy for 10 Years: A Mixed-Methods Analysis of Women's Decision Making in an Online Breast Cancer Forum.

Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare9060688

An additional 5 years of treatment with adjuvant hormonal therapy, to complete 10 years of medication, is recommended to reduce the risk of breast cancer recurrence. Yet professionals and patients should balance this benefit against side ef…